126 related articles for article (PubMed ID: 38135017)
41. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
[TBL] [Abstract][Full Text] [Related]
42. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
[TBL] [Abstract][Full Text] [Related]
43. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
[TBL] [Abstract][Full Text] [Related]
44. Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11).
Kim JY; Park S; Im SA; Kim SB; Sohn J; Lee KS; Chae YS; Lee KH; Kim JH; Im YH; Kim TY; Lee KH; Ahn JH; Kim GM; Park IH; Lee SJ; Han HS; Kim SH; Jung KH; Park YH;
Cancer Commun (Lond); 2019 May; 39(1):29. PubMed ID: 31138332
[TBL] [Abstract][Full Text] [Related]
45. Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings.
Michalová Z; Székiová E; Blaško J; Vanický I
Neoplasma; 2023 Feb; 70(1):15-35. PubMed ID: 36573482
[TBL] [Abstract][Full Text] [Related]
46. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
[TBL] [Abstract][Full Text] [Related]
47. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
[TBL] [Abstract][Full Text] [Related]
48. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
Baldwin RM; Owzar K; Zembutsu H; Chhibber A; Kubo M; Jiang C; Watson D; Eclov RJ; Mefford J; McLeod HL; Friedman PN; Hudis CA; Winer EP; Jorgenson EM; Witte JS; Shulman LN; Nakamura Y; Ratain MJ; Kroetz DL
Clin Cancer Res; 2012 Sep; 18(18):5099-109. PubMed ID: 22843789
[TBL] [Abstract][Full Text] [Related]
49. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
Kurt S; Can G
Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
[TBL] [Abstract][Full Text] [Related]
50. Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast cancer.
Rosenbaek F; Holm HS; Hjelmborg JVB; Ewertz M; Jensen JD
Support Care Cancer; 2020 Aug; 28(8):3763-3769. PubMed ID: 31828491
[TBL] [Abstract][Full Text] [Related]
51. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
52. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Kuriyama A; Endo K
Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
[TBL] [Abstract][Full Text] [Related]
53. Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
Bland KA; Kirkham AA; Bovard J; Shenkier T; Zucker D; McKenzie DC; Davis MK; Gelmon KA; Campbell KL
Clin Breast Cancer; 2019 Dec; 19(6):411-422. PubMed ID: 31601479
[TBL] [Abstract][Full Text] [Related]
54. Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
Hiramoto S; Asano H; Miyamoto T; Takegami M; Kawabata A
PLoS One; 2021; 16(12):e0261473. PubMed ID: 34972132
[TBL] [Abstract][Full Text] [Related]
55. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
[TBL] [Abstract][Full Text] [Related]
56. The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.
Simon NB; Danso MA; Alberico TA; Basch E; Bennett AV
Qual Life Res; 2017 Oct; 26(10):2763-2772. PubMed ID: 28664460
[TBL] [Abstract][Full Text] [Related]
57. Reliability and Validity of the EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale) among Thai Women with Breast Cancer Undergoing Taxane-Based Chemotherapy.
Rattanakrong N; Thipprasopchock S; Siriphorn A; Boonyong S
Asian Pac J Cancer Prev; 2022 May; 23(5):1547-1553. PubMed ID: 35633537
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.
Ocean AJ; Vahdat LT
Support Care Cancer; 2004 Sep; 12(9):619-25. PubMed ID: 15258838
[TBL] [Abstract][Full Text] [Related]
59. Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.
Speck RM; DeMichele A; Farrar JT; Hennessy S; Mao JJ; Stineman MG; Barg FK
Support Care Cancer; 2012 Oct; 20(10):2433-9. PubMed ID: 22231480
[TBL] [Abstract][Full Text] [Related]
60. Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial.
Mazzega-Fabbro C; Polesel J; Spazzapan S; Meneghetti L; Montagner D; Tabaro G; Bartoletti M; Puglisi F
Clin Breast Cancer; 2023 Jun; 23(4):447-453. PubMed ID: 36997403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]